We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

32 hedge funds and large institutions have $7.45M invested in AYTU BioPharma in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

199% more capital invested

Capital invested by funds: $2.49M → $7.45M (+$4.96M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

7.64% more ownership

Funds ownership: 30.42% → 38.06% (+7.6%)

3% more funds holding

Funds holding: 31 → 32 (+1)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
+$963K
2
KWM
Kanen Wealth Management
Florida
+$891K
3
SCM
Stonepine Capital Management
Oregon
+$542K
4
FIA
FNY Investment Advisers
New York
+$55.8K
5
Two Sigma Investments
Two Sigma Investments
New York
+$54.4K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$69.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$36.6K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17.8K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.81K
5
TRCT
Tower Research Capital (TRC)
New York
-$3.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$2.37M – – –
SCM
2
Stonepine Capital Management
Oregon
$1.77M +$542K +348,955 +75%
AIC
3
AWM Investment Company
New York
$1.35M +$963K +619,874 New
KWM
4
Kanen Wealth Management
Florida
$1.25M +$891K +573,358 New
Renaissance Technologies
5
Renaissance Technologies
New York
$196K +$20.3K +13,090 +17%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$117K -$116 -75 -0.1%
FIA
7
FNY Investment Advisers
New York
$78K +$55.8K +35,921 New
Two Sigma Investments
8
Two Sigma Investments
New York
$76.4K +$54.4K +35,035 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$60.8K – – –
BlackRock
10
BlackRock
New York
$49.7K – – –
HF
11
HRT Financial
New York
$43K +$31K +19,988 New
JIP
12
Jaffetilchin Investment Partners
Florida
$38K – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$22K -$6.81K -4,385 -30%
MCM
14
MAI Capital Management
Ohio
$7.79K – – –
UBS Group
15
UBS Group
Switzerland
$6.64K +$4.33K +2,785 +1,063%
TRCT
16
Tower Research Capital (TRC)
New York
$5.53K -$3.34K -2,153 -46%
Osaic Holdings
17
Osaic Holdings
Arizona
$654 – – –
Morgan Stanley
18
Morgan Stanley
New York
$624 -$6 -4 -1%
SS
19
SBI Securities
Japan
$460 +$233 +150 +246%
Wells Fargo
20
Wells Fargo
California
$277 +$5 +3 +2%
CIBC Private Wealth Group
21
CIBC Private Wealth Group
Georgia
$181 – – –
Bank of America
22
Bank of America
North Carolina
$137 -$62 -40 -39%
Raymond James Financial
23
Raymond James Financial
Florida
$120 +$85 +55 New
Group One Trading
24
Group One Trading
Illinois
$81 – – –
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$50 – – –
1
2

AYTU Hedge Fund Activity: Q2 2025 in Review

32 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q2 2025, worth a combined $7.45M — up 199% from $2.49M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AYTU positions and 5 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was AWM Investment Company, opening a new position worth an estimated $963K. The largest seller was Armistice Capital, exiting entirely with an estimated $69.1K sold.

  • 32 institutional investors held AYTU BioPharma (AYTU) as of Q2 2025, up from 31 in Q1 2025.
  • Funds reported $7.45M of AYTU BioPharma stock for Q2 2025, up 199% quarter-over-quarter.
  • 7 funds opened new AYTU BioPharma positions in Q2 2025 and 5 closed out, a net change of +2 holders.
  • The largest AYTU BioPharma buyer in Q2 2025 was AWM Investment Company, an estimated $963K added.
  • The largest AYTU BioPharma seller in Q2 2025 was Armistice Capital, an estimated $69.1K sold.

Based on aggregated 13F filings for Q2 2025.